Wireless system continuously tracks pH, glucose, and lactate in perfusate and bile during donor liver preservation.
Los Angeles, CA – July 14, 2026 – More than 100,000 people in the United States are waiting for a lifesaving organ transplant. For patients in need of a liver transplant, determining whether a donor liver is healthy enough to transplant is a critical part of the process. Yangzhi Zhu, PhD, Principal Investigator and Assistant Professor at the Terasaki Institute for Biomedical Innovation, and collaborators at Mayo Clinic in Arizona have developed a real-time biosensing platform designed to help answer that question during donor liver preservation.
